{"id":"https://openalex.org/W2087528124","doi":"https://doi.org/10.1111/1755-5922.12000","title":"GLP \u20101 Receptor Agonists: Effects on Cardiovascular Risk Reduction","display_name":"GLP \u20101 Receptor Agonists: Effects on Cardiovascular Risk Reduction","alternate_titles":[],"publication_year":2012,"publication_date":"2012-07-01","ids":{"openalex":"https://openalex.org/W2087528124","doi":"https://doi.org/10.1111/1755-5922.12000","mag":"2087528124","pmid":"https://pubmed.ncbi.nlm.nih.gov/23865382"},"language":"en","primary_location":{"id":"doi:10.1111/1755-5922.12000","doi":"https://doi.org/10.1111/1755-5922.12000","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1755-5922.12000","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1755-5922.12000","source":{"id":"https://openalex.org/S73613154","display_name":"Cardiovascular Therapeutics","issn_l":"1755-5914","issn":["1755-5914","1755-5922"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2087528124"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1755-5922.12000","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111842243","display_name":"Daniel Lorber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I2801107848","display_name":"New York Hospital Queens","ror":"https://ror.org/01j17xg39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801107848"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel Lorber","raw_affiliation_strings":["Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA","Division of Endocrinology, New York Hospital Queens, Flushing, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA","institution_ids":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"raw_affiliation_string":"Division of Endocrinology, New York Hospital Queens, Flushing, NY, USA","institution_ids":["https://openalex.org/I2801107848"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5111842243"],"corresponding_institution_ids":["https://openalex.org/I205783295","https://openalex.org/I2801107848","https://openalex.org/I4387153466"],"apc_list":{"value":2160,"currency":"USD","value_usd":2160},"apc_paid":null,"fwci":1.4132,"has_fulltext":true,"cited_by_count":78,"citation_normalized_percentile":{"value":0.80068532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"31","issue":"4","first_page":"238","last_page":"249"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9610000252723694},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9340000152587891},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9670000076293945},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.9290000200271606},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.6159999966621399},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6399999856948853},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.8600000143051147},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9670000076293945},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7639999985694885},{"id":"https://openalex.org/keywords/cardiomyocytes","display_name":"cardiomyocytes","score":0.921999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9489333629608154},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9354228973388672},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.8540478348731995},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.6675879955291748},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.6378921270370483},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.5921761393547058},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5886542797088623},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5569079518318176},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.535027027130127},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5183883309364319},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4916563630104065},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.46742957830429077},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.46408817172050476},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4605400264263153},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.35566845536231995},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3400895595550537},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.3131878972053528},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2852364182472229}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/1755-5922.12000","doi":"https://doi.org/10.1111/1755-5922.12000","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1755-5922.12000","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1755-5922.12000","source":{"id":"https://openalex.org/S73613154","display_name":"Cardiovascular Therapeutics","issn_l":"1755-5914","issn":["1755-5914","1755-5922"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Therapeutics","raw_type":"journal-article"},{"id":"doi:10.1111/cdr.12000","doi":"https://doi.org/10.1111/cdr.12000","is_oa":false,"landing_page_url":"https://doi.org/10.1111/cdr.12000","pdf_url":null,"source":{"id":"https://openalex.org/S73613154","display_name":"Cardiovascular Therapeutics","issn_l":"1755-5914","issn":["1755-5914","1755-5922"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Therapeutics","raw_type":"journal-article"},{"id":"pmid:23865382","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23865382","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/1755-5922.12000","doi":"https://doi.org/10.1111/1755-5922.12000","is_oa":true,"landing_page_url":"https://doi.org/10.1111/1755-5922.12000","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1755-5922.12000","source":{"id":"https://openalex.org/S73613154","display_name":"Cardiovascular Therapeutics","issn_l":"1755-5914","issn":["1755-5914","1755-5922"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2087528124.pdf","grobid_xml":"https://content.openalex.org/works/W2087528124.grobid-xml"},"referenced_works_count":92,"referenced_works":["https://openalex.org/W1518543897","https://openalex.org/W1559082056","https://openalex.org/W1973901069","https://openalex.org/W1977179808","https://openalex.org/W1981183973","https://openalex.org/W1982294133","https://openalex.org/W1986331352","https://openalex.org/W1987538170","https://openalex.org/W1994743271","https://openalex.org/W1995209325","https://openalex.org/W1995773576","https://openalex.org/W1997332398","https://openalex.org/W1999381401","https://openalex.org/W1999843320","https://openalex.org/W2000976083","https://openalex.org/W2005230361","https://openalex.org/W2010000105","https://openalex.org/W2016622896","https://openalex.org/W2017044017","https://openalex.org/W2019566854","https://openalex.org/W2028092672","https://openalex.org/W2029071587","https://openalex.org/W2030562170","https://openalex.org/W2030809658","https://openalex.org/W2032322539","https://openalex.org/W2033665483","https://openalex.org/W2033892901","https://openalex.org/W2043900831","https://openalex.org/W2044160793","https://openalex.org/W2046535650","https://openalex.org/W2048809940","https://openalex.org/W2055678371","https://openalex.org/W2055824736","https://openalex.org/W2055849242","https://openalex.org/W2061691264","https://openalex.org/W2063400466","https://openalex.org/W2070710390","https://openalex.org/W2071539395","https://openalex.org/W2071835038","https://openalex.org/W2075024723","https://openalex.org/W2078090288","https://openalex.org/W2081283952","https://openalex.org/W2083783526","https://openalex.org/W2098459806","https://openalex.org/W2102400698","https://openalex.org/W2104818363","https://openalex.org/W2105926302","https://openalex.org/W2107949845","https://openalex.org/W2108646121","https://openalex.org/W2113367996","https://openalex.org/W2114481251","https://openalex.org/W2118762421","https://openalex.org/W2120431951","https://openalex.org/W2122360768","https://openalex.org/W2123946565","https://openalex.org/W2125064105","https://openalex.org/W2126528640","https://openalex.org/W2128077095","https://openalex.org/W2129404964","https://openalex.org/W2129730863","https://openalex.org/W2130471781","https://openalex.org/W2131278438","https://openalex.org/W2132600402","https://openalex.org/W2137352234","https://openalex.org/W2138077952","https://openalex.org/W2138290933","https://openalex.org/W2139485303","https://openalex.org/W2139562487","https://openalex.org/W2140682563","https://openalex.org/W2141917858","https://openalex.org/W2142097676","https://openalex.org/W2142400535","https://openalex.org/W2150095170","https://openalex.org/W2150913805","https://openalex.org/W2154595662","https://openalex.org/W2156133857","https://openalex.org/W2157677292","https://openalex.org/W2157869836","https://openalex.org/W2158778171","https://openalex.org/W2159205789","https://openalex.org/W2160001758","https://openalex.org/W2161474086","https://openalex.org/W2164416879","https://openalex.org/W2169849811","https://openalex.org/W2170271481","https://openalex.org/W2170606300","https://openalex.org/W2171294019","https://openalex.org/W2172124430","https://openalex.org/W2229098171","https://openalex.org/W2510708214","https://openalex.org/W2916392902","https://openalex.org/W4252795044"],"related_works":["https://openalex.org/W2007217090","https://openalex.org/W2795534327","https://openalex.org/W3013791601","https://openalex.org/W2110786185","https://openalex.org/W3211003663","https://openalex.org/W2085341566","https://openalex.org/W3172134520","https://openalex.org/W2804938814","https://openalex.org/W3155587737","https://openalex.org/W4389088705"],"abstract_inverted_index":{"Comorbid":[0],"obesity,":[1],"dyslipidemia,":[2],"and":[3,21,40,54,67,72,113,121,129,138],"hypertension":[4],"place":[5],"patients":[6,31,76],"with":[7,32,75,77],"type":[8],"2":[9],"diabetes":[10],"(T2DM)":[11],"at":[12],"greatly":[13],"increased":[14],"risk":[15,44,108],"of":[16,65,83,106],"cardiovascular":[17],"(CV)":[18],"disease-related":[19],"morbidity":[20],"mortality.":[22],"An":[23],"urgent":[24],"need":[25],"exists":[26],"for":[27,30],"effective":[28],"treatment":[29,98],"T2DM":[33,97],"that":[34],"encompasses":[35],"glycemic":[36],"control,":[37],"weight":[38,112],"loss,":[39],"reduction":[41],"in":[42,69,86,96,125,126],"CV":[43,107],"factors.":[45],"The":[46],"glucagon-like":[47],"peptide-1":[48],"receptor":[49],"agonists":[50],"(GLP-1":[51],"RAs)":[52],"liraglutide":[53,66],"exenatide":[55,68],"are":[56],"incretin-based":[57],"antidiabetes":[58],"agents.":[59],"This":[60],"review":[61],"examines":[62],"CV-associated":[63],"effects":[64,134],"animal":[70,130],"models":[71],"clinical":[73],"trials":[74],"T2DM.":[78],"Studies":[79],"support":[80],"the":[81],"effectiveness":[82],"GLP-1":[84,90],"RAs":[85,91],"reducing":[87],"hyperglycemia.":[88],"Further,":[89],"represent":[92],"a":[93,103],"significant":[94,111],"advance":[95],"because":[99],"they":[100],"uniquely":[101],"affect":[102],"broad":[104],"array":[105],"factors":[109],"through":[110,132],"systolic":[114],"blood":[115],"pressure":[116],"reduction,":[117],"improved":[118],"lipid":[119],"levels,":[120],"possibly,":[122],"as":[123],"shown":[124],"vitro":[127],"studies":[128],"models,":[131],"direct":[133],"on":[135],"cardiac":[136],"myocytes":[137],"endothelium.":[139]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2087528124","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":13}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}
